These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3033241)

  • 21. Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazoline.
    Venuti MC; Stephenson RA; Alvarez R; Bruno JJ; Strosberg AM
    J Med Chem; 1988 Nov; 31(11):2136-45. PubMed ID: 2846839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
    Price B; Pyne NJ; Houslay MD
    Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel class of cardiotonic agents: synthesis and biological evaluation of pyridazino[4,5-b]indoles with cyclic AMP phosphodiesterases inhibiting properties.
    Monge A; Aldana I; Losa MJ; Font M; Castiella E; Frechilla D; Cenarruzabeitia E; Martinez de Irujo JJ; Lopez-Unzu J; Alberdi E
    J Pharm Sci; 1993 May; 82(5):526-30. PubMed ID: 8395600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple molecular forms of phosphodiesterase and the regulation of cardiac muscle contractility.
    Weishaar RE; Kobylarz-Singer DC; Quade MM; Steffen RP; Kaplan HR
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):513-27. PubMed ID: 2831259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spirocyclopropane compounds II. Synthesis and biological activities of spiro[cyclopropane-1,2-[2H]indo]-3'(1'H)-ones.
    Kawada M; Sugihara H; Mikami I; Kawai K; Kuzuna S; Noguchi S; Sanno Y
    Chem Pharm Bull (Tokyo); 1981 Jul; 29(7):1912-9. PubMed ID: 6975665
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.
    Berger C; Meyer W; Scholz H; Starbatty J
    Arzneimittelforschung; 1985; 35(11):1668-73. PubMed ID: 2418846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents.
    Sircar I; Duell BL; Bobowski G; Bristol JA; Evans DB
    J Med Chem; 1985 Oct; 28(10):1405-13. PubMed ID: 2864447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of SK&F 95654, a novel phosphodiesterase inhibitor, on cardiovascular, respiratory and platelet function.
    Murray KJ; Eden RJ; Dolan JS; Grimsditch DC; Stutchbury CA; Patel B; Knowles A; Worby A; Lynham JA; Coates WJ
    Br J Pharmacol; 1992 Oct; 107(2):463-70. PubMed ID: 1422592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular pharmacology of RS-1893, an orally active cardiotonic agent with arterial and venous vasodilator actions.
    Miyake S; Shiga H; Koike H; Mizuno H; Yorikane R; Oda T; Iijima Y; Kumakura S; Morisawa Y
    Jpn J Pharmacol; 1988 Jul; 47(3):273-83. PubMed ID: 2851676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inotropic responses to selective (RO 20-1724 and SQ 65,442) and nonselective (trequinsin) inhibitors of cyclic AMP-specific class IV phosphodiesterase in newborn, immature, and adult rabbit myocardium.
    Oquist NL; Strada SJ; Artman M
    Pediatr Res; 1992 Mar; 31(3):300-4. PubMed ID: 1313959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogues of imazodan (CI-914).
    Sircar I; Morrison GC; Burke SE; Skeean R; Weishaar RE
    J Med Chem; 1987 Oct; 30(10):1724-8. PubMed ID: 3656349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemistry of indoles carrying a basic function, Part 3. Synthesis of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H)-ones with antihypoxic effects.
    Moldvai I; Gács-Baitz E; Balázs M; Incze M; Szántay C
    Arch Pharm (Weinheim); 1996 Dec; 329(12):541-9. PubMed ID: 9038422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (Imidazolylphenyl)pyrrol-2-one inhibitors of cardiac cAMP phosphodiesterase.
    Lampe JW; Chou YL; Hanna RG; Di Meo SV; Erhardt PW; Hagedorn AA; Ingebretsen WR; Cantor E
    J Med Chem; 1993 Apr; 36(8):1041-7. PubMed ID: 8386770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel class of cardiotonic agents: synthesis and biological evaluation of 5-substituted 3,6-dihydrothiadiazin-2-ones with cyclic AMP phosphodiesterase inhibiting and myofibrillar calcium sensitizing properties.
    Forest MC; Lahouratate P; Martin M; Nadler G; Quiniou MJ; Zimmermann RG
    J Med Chem; 1992 Jan; 35(1):163-72. PubMed ID: 1310113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
    Weishaar RE; Quade MM; Schenden JA; Evans DB
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H; Kaheinen P; Levijoki J; Lindén IB
    Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of cyclic AMP phosphodiesterase. 2. Structural variations of N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro- 2-oxoimidazo[2,1-b]quinazolin-7-yl)-oxy]butyramide (RS-82856).
    Venuti MC; Jones GH; Alvarez R; Bruno JJ
    J Med Chem; 1987 Feb; 30(2):303-18. PubMed ID: 3027339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New 6'-Amino-5'-cyano-2-oxo-1,2-dihydro-1'
    Dotsenko VV; Jassim NT; Temerdashev AZ; Abdul-Hussein ZR; Aksenov NA; Aksenova IV
    Molecules; 2023 Apr; 28(7):. PubMed ID: 37049923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
    Edes I; Kiss E; Kitada Y; Powers FM; Papp JG; Kranias EG; Solaro RJ
    Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.